Similar articles

• Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin.

  Thuluvath PJ, Pande H, Maygers J. Thuluvath PJ, et al. Dig Dis Sci. 2003 Mar;48(3):594-7. doi: 10.1023/a:1022509304694. Dig Dis Sci. 2003. PMID: 12757175 Clinical Trial.
• Combination therapy for chronic hepatitis C.

  Marcellin P. Marcellin P. Ital J Gastroenterol Hepatol. 1999 Mar;31(2):135-6. Ital J Gastroenterol Hepatol. 1999. PMID: 10363199 No abstract available.
• Amantadine in the treatment of patients with chronic hepatitis C.

  Foster GR. Foster GR. Ital J Gastroenterol Hepatol. 1998 Dec;30(6):614-5. Ital J Gastroenterol Hepatol. 1998. PMID: 10076784 No abstract available.
• [Combination therapy for chronic viral hepatitis C].

  Zeuzem S. Zeuzem S. Dtsch Med Wochenschr. 2003 Feb 21;128(8):370-4. doi: 10.1055/s-2003-37369. Dtsch Med Wochenschr. 2003. PMID: 12594622 Review. German. No abstract available.
• [High dose repeat therapy in previously treated patients with chronic hepatitis C].

  Hoepffner N, Paul KA, Nikodem AB, Teuber G. Hoepffner N, et al. Dtsch Med Wochenschr. 2006 Mar 17;131(11):543-4. doi: 10.1055/s-2006-933693. Dtsch Med Wochenschr. 2006. PMID: 16538557 Review. German. No abstract available.